Skip to main content Help with accessibility Skip to main navigation

TOLVAPTAN tablets (Samsca®) for the treatment of hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Last Updated: 22 May 2019

Body System: Endocrine System

Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of TOLVAPTAN tablets (Samsca®), by specialists only, for the treatment of hyponatraemia secondary to SIADH due to any cause.